1-12 of 12
Ming Tan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B31: Tumor-intrinsic B7-H3 regulates drug resistance, metabolism, and pathogenesis in ovarian cancer

Holly Taylor, Jaroslav Slamecka, Alla Musiyenko, Elaine Gavin, Tiffany S. Norton, Ileana Aragon, Taylor Young, Jennifer Scalici, Rodney P. Rocconi, Ming Tan, Luciana Madeira da Silva
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B31.
https://doi.org/10.1158/1557-3265.OVCA17-B31
Published: 01 August 2018
View article titled, Abstract B31: Tumor-intrinsic B7-H3 regulates drug resistance, metabolism, and pathogenesis in ovarian cancer
Journal Articles

Drug response indicator test (DRIT): A predictive diagnostic laboratory service for anticancer treatment of individual patients.

Paul Ts'o, Stephen Lesko, ZP Lum, Scott Deamond, Enzhi Shan, David Zhou, John Daniel, David Van Echo, Katherine Tkaczuk, Nancy Tait, Olga Ioffe, Naimish Pandya, William Rodgers, Ming Tan
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19_Supplement): B35.
Published: 15 August 2014
View article titled, Drug response indicator test (DRIT): A predictive diagnostic laboratory service for anticancer treatment of individual patients.
Journal Articles

Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

Ivana Gojo, Ming Tan, Hong-Bin Fang, Mariola Sadowska, Rena Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rakesh K. Srivastava, Igor Espinoza-Delgado, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1838–1851.
https://doi.org/10.1158/1078-0432.CCR-12-3165
Published: 02 April 2013
View article titled, Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
Open the PDF for Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

Aaron P. Rapoport, Edward A. Stadtmauer, Nicole Aqui, Dan Vogl, Anne Chew, Hong-Bin Fang, Stephen Janofsky, Kelly Yager, Elizabeth Veloso, Zhaohui Zheng, Todd Milliron, Sandra Westphal, Julio Cotte, Hong Huynh, Andrea Cannon, Saul Yanovich, Gorgun Akpek, Ming Tan, Kristen Virts, Kathleen Ruehle, Carolynn Harris, Sunita Philip, Robert H. Vonderheide, Bruce L. Levine, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4499–4507.
https://doi.org/10.1158/1078-0432.CCR-09-0418
Published: 01 July 2009
View article titled, Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells
Open the PDF for Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells in another window
Includes: Supplementary data
Journal Articles

Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

Ken Shiozawa, Takeo Nakanishi, Ming Tan, Hong-Bin Fang, Wen-chyi Wang, Martin J. Edelman, David Carlton, Ivana Gojo, Edward A. Sausville, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (5): 1698–1707.
https://doi.org/10.1158/1078-0432.CCR-08-1587
Published: 27 February 2009
View article titled, Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
Open the PDF for Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias in another window
Includes: Supplementary data
Journal Articles

Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

Jing Lu, Ming Tan, Wen-Chien Huang, Ping Li, Hua Guo, Ling-Ming Tseng, Xiao-hua Su, Wen-Tao Yang, Warapen Treekitkarnmongkol, Michael Andreeff, Fraser Symmans, Dihua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1326–1334.
https://doi.org/10.1158/1078-0432.CCR-08-0954
Published: 19 February 2009
View article titled, Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Open the PDF for Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance in another window
Includes: Supplementary data
Journal Articles

Elevated Expression of Glutathione S-Transferase π and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone

Lisa Schumaker, Nikolaos Nikitakis, Olga Goloubeva, Ming Tan, Rodney Taylor, Kevin J. Cullen
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (18): 5877–5883.
https://doi.org/10.1158/1078-0432.CCR-08-0998
Published: 14 September 2008
View article titled, Elevated Expression of Glutathione <em>S</em>-Transferase π and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone
Open the PDF for Elevated Expression of Glutathione <em>S</em>-Transferase π and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone in another window
Journal Articles

Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers

Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne, Kristine S. Klos, Keng-Hsueh Lan, Ying Yang, Wentao Yang, Terry L. Smith, Daren Shi, Dihua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6779–6788.
https://doi.org/10.1158/1078-0432.CCR-04-0112
Published: 22 October 2004
View article titled, Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers
Open the PDF for Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers in another window
Journal Articles

Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients

Takeo Nakanishi, Judith E. Karp, Ming Tan, L. Austin Doyle, Todd Peters, Weidong Yang, David Wei, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3320–3328.
Published: 05 September 2003
View article titled, Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients
Open the PDF for Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients in another window
Journal Articles

A Pilot Study of Protracted Topotecan Dosing Using a Pharmacokinetically Guided Dosing Approach in Children with Solid Tumors

Victor M. Santana, William C. Zamboni, Mark N. Kirstein, Ming Tan, Tiebin Liu, Amar Gajjar, Peter J. Houghton, Clinton F. Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 633–640.
Published: 01 February 2003
View article titled, A Pilot Study of Protracted Topotecan Dosing Using a Pharmacokinetically Guided Dosing Approach in Children with Solid Tumors
Open the PDF for A Pilot Study of Protracted Topotecan Dosing Using a Pharmacokinetically Guided Dosing Approach in Children with Solid Tumors in another window
Journal Articles

Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin

Lee S. Schwartzberg, Istvan Petak, Clinton Stewart, P. Kellie Turner, Jeri Ashley, David M. Tillman, Leslie Douglas, Ming Tan, Catherine Billups, Rudolf Mihalik, Alva Weir, Kurt Tauer, Steve Shope, Janet A. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2488–2498.
Published: 01 August 2002
View article titled, Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin
Open the PDF for Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin in another window
Journal Articles

Antitumor Activity of Temozolomide Combined with Irinotecan Is Partly Independent of O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Phenotypes in Xenograft Models

Peter J. Houghton, Clinton F. Stewart, Pamela J. Cheshire, Lois B. Richmond, Mark N. Kirstein, Catherine A. Poquette, Ming Tan, Henry S. Friedman, Thomas P. Brent
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 4110–4118.
Published: 01 October 2000
View article titled, Antitumor Activity of Temozolomide Combined with Irinotecan Is Partly Independent of <em>O</em><sup>6</sup>-Methylguanine-DNA Methyltransferase and Mismatch Repair Phenotypes in Xenograft Models
Open the PDF for Antitumor Activity of Temozolomide Combined with Irinotecan Is Partly Independent of <em>O</em><sup>6</sup>-Methylguanine-DNA Methyltransferase and Mismatch Repair Phenotypes in Xenograft Models in another window